Titre : Déméthylation

Déméthylation : Questions médicales fréquentes

Termes MeSH sélectionnés :

Multimodal Imaging
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Déméthylation : Questions médicales les plus fréquentes", "headline": "Déméthylation : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Déméthylation : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-25", "dateModified": "2025-04-19", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Déméthylation" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Désalkylation", "url": "https://questionsmedicales.fr/mesh/D003640", "about": { "@type": "MedicalCondition", "name": "Désalkylation", "code": { "@type": "MedicalCode", "code": "D003640", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G03.219" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Déméthylation de l'ADN", "alternateName": "DNA Demethylation", "url": "https://questionsmedicales.fr/mesh/D000073399", "about": { "@type": "MedicalCondition", "name": "Déméthylation de l'ADN", "code": { "@type": "MedicalCode", "code": "D000073399", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G03.219.500.500" } } } ], "about": { "@type": "MedicalCondition", "name": "Déméthylation", "alternateName": "Demethylation", "code": { "@type": "MedicalCode", "code": "D000073398", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Samuel E Ross", "url": "https://questionsmedicales.fr/author/Samuel%20E%20Ross", "affiliation": { "@type": "Organization", "name": "Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, Australia." } }, { "@type": "Person", "name": "Ozren Bogdanovic", "url": "https://questionsmedicales.fr/author/Ozren%20Bogdanovic", "affiliation": { "@type": "Organization", "name": "Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, Australia." } }, { "@type": "Person", "name": "Yaxin Xiong", "url": "https://questionsmedicales.fr/author/Yaxin%20Xiong", "affiliation": { "@type": "Organization", "name": "Department of Environmental Sciences, University of California, Riverside, California 92521, United States." } }, { "@type": "Person", "name": "Qingyang Shi", "url": "https://questionsmedicales.fr/author/Qingyang%20Shi", "affiliation": { "@type": "Organization", "name": "Department of Environmental Sciences, University of California, Riverside, California 92521, United States." } }, { "@type": "Person", "name": "Daniel Schlenk", "url": "https://questionsmedicales.fr/author/Daniel%20Schlenk", "affiliation": { "@type": "Organization", "name": "Department of Environmental Sciences, University of California, Riverside, California 92521, United States." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Single-cell multimodal imaging uncovers energy conversion pathways in biohybrids.", "datePublished": "2023-07-27", "url": "https://questionsmedicales.fr/article/37500951", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41557-023-01285-z" } }, { "@type": "ScholarlyArticle", "name": "Multimodal Imaging Characteristics and Risk Factors Analysis of Waldenström Macroglobulinemia Retinopathy.", "datePublished": "2023-03-22", "url": "https://questionsmedicales.fr/article/36963604", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ajo.2023.03.011" } }, { "@type": "ScholarlyArticle", "name": "The impact of acute COVID-19 on the retinal microvasculature assessed with multimodal imaging.", "datePublished": "2022-11-05", "url": "https://questionsmedicales.fr/article/36334115", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00417-022-05887-0" } }, { "@type": "ScholarlyArticle", "name": "Characteristics of brittle cornea syndrome by multimodal imaging modalities: a case report.", "datePublished": "2023-09-15", "url": "https://questionsmedicales.fr/article/37710225", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12886-023-03123-9" } }, { "@type": "ScholarlyArticle", "name": "A case of choroidal melanocytosis observed by multimodal imaging with laser speckle flowgraphy.", "datePublished": "2023-04-26", "url": "https://questionsmedicales.fr/article/37101259", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12886-023-02933-1" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Métabolisme", "item": "https://questionsmedicales.fr/mesh/D008660" }, { "@type": "ListItem", "position": 3, "name": "Désalkylation", "item": "https://questionsmedicales.fr/mesh/D003640" }, { "@type": "ListItem", "position": 4, "name": "Déméthylation", "item": "https://questionsmedicales.fr/mesh/D000073398" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Déméthylation - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Déméthylation", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-02", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Déméthylation", "description": "Comment diagnostiquer une déméthylation anormale ?\nQuels marqueurs sont utilisés pour la déméthylation ?\nQuels tests sanguins peuvent indiquer une déméthylation ?\nLa biopsie est-elle nécessaire pour diagnostiquer la déméthylation ?\nQuels symptômes peuvent alerter sur une déméthylation ?", "url": "https://questionsmedicales.fr/mesh/D000073398?mesh_terms=Multimodal+Imaging&page=6#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Déméthylation", "description": "Quels symptômes sont associés à la déméthylation ?\nLa déméthylation peut-elle causer des maladies ?\nY a-t-il des signes cliniques de déméthylation ?\nLes symptômes varient-ils selon l'âge ?\nLa déméthylation affecte-t-elle le système immunitaire ?", "url": "https://questionsmedicales.fr/mesh/D000073398?mesh_terms=Multimodal+Imaging&page=6#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Déméthylation", "description": "Comment prévenir la déméthylation ?\nLes suppléments peuvent-ils aider ?\nLe stress influence-t-il la déméthylation ?\nL'exercice physique a-t-il un impact ?\nLes toxines environnementales jouent-elles un rôle ?", "url": "https://questionsmedicales.fr/mesh/D000073398?mesh_terms=Multimodal+Imaging&page=6#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Déméthylation", "description": "Quels traitements existent pour la déméthylation ?\nLa nutrition peut-elle influencer la déméthylation ?\nLes thérapies épigénétiques sont-elles efficaces ?\nPeut-on prévenir la déméthylation par des médicaments ?\nLes traitements sont-ils personnalisés ?", "url": "https://questionsmedicales.fr/mesh/D000073398?mesh_terms=Multimodal+Imaging&page=6#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Déméthylation", "description": "Quelles complications peuvent survenir ?\nLa déméthylation est-elle réversible ?\nQuels risques sont associés à la déméthylation ?\nLa déméthylation peut-elle affecter la fertilité ?\nY a-t-il des effets à long terme ?", "url": "https://questionsmedicales.fr/mesh/D000073398?mesh_terms=Multimodal+Imaging&page=6#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Déméthylation", "description": "Quels sont les facteurs de risque de déméthylation ?\nL'hérédité joue-t-elle un rôle ?\nLes maladies chroniques augmentent-elles le risque ?\nLe mode de vie influence-t-il la déméthylation ?\nLes infections peuvent-elles affecter la déméthylation ?", "url": "https://questionsmedicales.fr/mesh/D000073398?mesh_terms=Multimodal+Imaging&page=6#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une déméthylation anormale ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques et des analyses de l'ADN peuvent révéler des modifications de méthylation." } }, { "@type": "Question", "name": "Quels marqueurs sont utilisés pour la déméthylation ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les marqueurs épigénétiques comme 5-méthylcytosine sont souvent analysés." } }, { "@type": "Question", "name": "Quels tests sanguins peuvent indiquer une déméthylation ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de métabolites et d'ADN circulant peuvent fournir des indices." } }, { "@type": "Question", "name": "La biopsie est-elle nécessaire pour diagnostiquer la déméthylation ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Une biopsie peut être nécessaire pour des analyses plus précises des tissus." } }, { "@type": "Question", "name": "Quels symptômes peuvent alerter sur une déméthylation ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes variés comme des troubles neurologiques ou des cancers peuvent survenir." } }, { "@type": "Question", "name": "Quels symptômes sont associés à la déméthylation ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent inclure des troubles cognitifs, des anomalies de croissance et des cancers." } }, { "@type": "Question", "name": "La déméthylation peut-elle causer des maladies ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est liée à des maladies comme le cancer et des troubles génétiques." } }, { "@type": "Question", "name": "Y a-t-il des signes cliniques de déméthylation ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des signes cliniques peuvent inclure des changements de comportement et des anomalies physiques." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent se manifester différemment selon l'âge et le développement." } }, { "@type": "Question", "name": "La déméthylation affecte-t-elle le système immunitaire ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut altérer la réponse immunitaire, augmentant le risque d'infections." } }, { "@type": "Question", "name": "Comment prévenir la déméthylation ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à prévenir la déméthylation." } }, { "@type": "Question", "name": "Les suppléments peuvent-ils aider ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des suppléments comme l'acide folique peuvent soutenir la méthylation." } }, { "@type": "Question", "name": "Le stress influence-t-il la déméthylation ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut affecter les mécanismes de méthylation." } }, { "@type": "Question", "name": "L'exercice physique a-t-il un impact ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "L'exercice régulier peut améliorer la santé épigénétique et la méthylation." } }, { "@type": "Question", "name": "Les toxines environnementales jouent-elles un rôle ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à certaines toxines peut perturber les mécanismes de méthylation." } }, { "@type": "Question", "name": "Quels traitements existent pour la déméthylation ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des thérapies géniques et des médicaments ciblés." } }, { "@type": "Question", "name": "La nutrition peut-elle influencer la déméthylation ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains nutriments comme l'acide folique peuvent moduler la méthylation." } }, { "@type": "Question", "name": "Les thérapies épigénétiques sont-elles efficaces ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Elles montrent un potentiel prometteur dans le traitement de certains cancers." } }, { "@type": "Question", "name": "Peut-on prévenir la déméthylation par des médicaments ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des inhibiteurs spécifiques peuvent être utilisés pour prévenir la déméthylation." } }, { "@type": "Question", "name": "Les traitements sont-ils personnalisés ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent être adaptés en fonction du profil génétique du patient." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des cancers, des troubles neurologiques et des maladies auto-immunes." } }, { "@type": "Question", "name": "La déméthylation est-elle réversible ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines modifications peuvent être réversibles, mais pas toutes." } }, { "@type": "Question", "name": "Quels risques sont associés à la déméthylation ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les risques incluent des maladies chroniques et des troubles de développement." } }, { "@type": "Question", "name": "La déméthylation peut-elle affecter la fertilité ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut influencer la fertilité en altérant la fonction reproductive." } }, { "@type": "Question", "name": "Y a-t-il des effets à long terme ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des effets à long terme peuvent inclure des prédispositions à diverses maladies." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de déméthylation ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'alimentation, le stress, et l'exposition à des toxines." } }, { "@type": "Question", "name": "L'hérédité joue-t-elle un rôle ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des facteurs génétiques peuvent influencer la déméthylation." } }, { "@type": "Question", "name": "Les maladies chroniques augmentent-elles le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies chroniques peuvent augmenter le risque de déméthylation." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il la déméthylation ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie malsain peut favoriser la déméthylation." } }, { "@type": "Question", "name": "Les infections peuvent-elles affecter la déméthylation ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections peuvent perturber les mécanismes de méthylation." } } ] } ] }

Sources (10000 au total)

Multimodal Imaging Characteristics and Risk Factors Analysis of Waldenström Macroglobulinemia Retinopathy.

To summarize the multimodal imaging features and analyze the risk factors of Waldenström macroglobulinemia retinopathy (WMR).... Retrospective, cross-sectional study.... Patients diagnosed with WM and underwent ophthalmic examination in Peking Union Medical College Hospital in the last decade were included. Multimodal imaging characteristics of WMR were summarized. Un... A total of 50 patients with WM were included in this study, and 28 patients had WMR in at least 1 eye. WMR was found to have worse LogMAR visual acuity (0.52 ± 0.54 vs 0.21 ± 0.18, P = .009) and was c... WMR has specific characteristics in ophthalmic examinations. Serum IgM levels and M protein are good predictors of WMR, which could attach important value of fundus examinations for patients with WM....

The impact of acute COVID-19 on the retinal microvasculature assessed with multimodal imaging.

To quantify retinal microvascular findings in the acute phase of COVID-19 using multimodal imaging and compare them with healthy, age-matched controls.... Hospitalized patients in the acute phase of COVID-19 without known systemic comorbidities (n = 75) and healthy controls (n = 101) aged 18-65 were enrolled in this prospective cross-sectional study. Th... Retinal findings were predominately observed in patients with severe disease (P = 0.006). Patients with severe disease were shown to have increased both mean vein diameter (Coef. = 19.28, 95% CI: 7.34... The severity of COVID-19 was significantly correlated with the presence of retinal microangiopathy, which could become a biomarker of angiopathy in patients with COVID-19....

Characteristics of brittle cornea syndrome by multimodal imaging modalities: a case report.

A report of a Brittle cornea syndrome (BCS) case with bluish scleral discoloration, keratoglobus, and myopia based on multimodal imaging modalities including in vivo confocal microscopy (IVCM), high-d... A 36-year-old Chinese female patient presented with significant bluish discoloration of the sclera in both eyes, extreme corneal thinning with increased corneal curvature, increased central corneal de... Timely diagnosis, early detection, and detailed follow-up are essential for BCS. There has been no report of a BCS evaluation performed by IVCM and corneal densitometry methods thus far in the literat...

A case of choroidal melanocytosis observed by multimodal imaging with laser speckle flowgraphy.

Choroidal melanocytosis is characterized by congenital diffuse melanin pigmentation with extensive parenchymal infiltration of spindle cells in the choroid; however, little is known about the choroida... A 56-year-old woman was referred to our hospital because of serous retinal detachment (SRD) in her left eye. At the initial examination, her best-corrected visual acuity (BCVA) was 1.5 oculus dexter (... Choroidal melanocytosis presented with chronic minor circulatory disturbances due to melanocyte proliferation in the choroid, but the markedly low MBR values by LSFG were dissociated from her retinal ...

Association of Diabetic Lesions and Retinal Nonperfusion Using Widefield Multimodal Imaging.

To evaluate the association of microvascular lesions on ultrawidefield (UWF) color fundus (CF) images with retinal nonperfusion (RNP) up to the midperiphery on single-capture widefield (WF) OCT angiog... Cross-sectional study.... Seventy-five eyes of 50 patients with mild to severe nonproliferative DR (NPDR) and proliferative DR (PDR) were included in this analysis.... ETDRS level and presence of predominantly peripheral lesions (PPLs) were assessed on UWF-CF images acquired with a Zeiss Clarus 700. Single-capture 65°-WF-OCTA was performed using a PlexElite prototyp... Association of diabetic lesions with RNP was calculated using Spearman correlations (r... Median RNP on WF-OCTA was 0 mm... The combination of UWF-CF imaging and single-capture WF-OCTA allows precise and noninvasive analysis of the retinal vasculature up to the midperiphery in patients with DR. The presence and extent of I... Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article....

Multimodal Imaging of Substantia Nigra in Parkinson's Disease with Levodopa-Induced Dyskinesia.

Degeneration of the substantia nigra (SN) may contribute to levodopa-induced dyskinesia (LID) in Parkinson's disease (PD), but the exact characteristics of SN in LID remain unclear.... To further understand the pathogenesis of patients with PD with LID (PD-LID), we explored the structural and functional characteristics of SN in PD-LID using multimodal magnetic resonance imaging (MRI... Twenty-nine patients with PD-LID, 37 patients with PD without LID (PD-nLID), and 28 healthy control subjects underwent T1-weighted MRI, quantitative susceptibility mapping, neuromelanin-sensitive MRI,... Compared with patients with PD-nLID and healthy control subjects, the quantitative susceptibility mapping values of SN pars compacta (SNpc) were significantly higher (P = 0.049 and P = 0.00002), and t... Our multimodal imaging findings highlight greater neurodegeneration in SN and the altered nigrostriatal connectivity in PD-LID. These characteristics provide a new perspective into the role of SN in t...